Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Shares Issued (2017 - 2025)

Rockwell Medical's Shares Issued history spans 12 years, with the latest figure at $7.8 million for Q3 2025.

  • For Q3 2025, Shares Issued rose 114.88% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 23.39%, while the annual FY2025 figure was $7.8 million, 23.23% down from the prior year.
  • Shares Issued reached $7.8 million in Q3 2025 per RMTI's latest filing, up from $3.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $13.8 million in Q3 2023 to a low of $107000.0 in Q3 2021.
  • Average Shares Issued over 4 years is $4.1 million, with a median of $2.9 million recorded in 2024.
  • The largest YoY upside for Shares Issued was 244.99% in 2024 against a maximum downside of 73.62% in 2024.
  • A 4-year view of Shares Issued shows it stood at $107000.0 in 2021, then soared by 926.17% to $1.1 million in 2023, then surged by 244.99% to $3.8 million in 2024, then soared by 105.91% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Shares Issued are $7.8 million (Q3 2025), $3.8 million (Q4 2024), and $3.6 million (Q3 2024).